---
title: "IVERSEN LESLIE L — Ownership Dossier"
canonical: https://whiteintel.dev/entity/b1871fde-825e-5b7a-90ab-e78468980826
json: https://whiteintel.dev/api/public/dossier/b1871fde-825e-5b7a-90ab-e78468980826
identifier: sec:0001291623
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# IVERSEN LESLIE L

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001291623`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/b1871fde-825e-5b7a-90ab-e78468980826  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/b1871fde-825e-5b7a-90ab-e78468980826  

## Ownership & control

### Holdings / subsidiaries

- **ACADIA PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/e0daead6-1fdc-534a-ae81-4152b4e37d9f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **IVERSEN LESLIE L**. Human view: https://whiteintel.dev/entity/b1871fde-825e-5b7a-90ab-e78468980826 · Structured JSON: https://whiteintel.dev/api/public/dossier/b1871fde-825e-5b7a-90ab-e78468980826._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._